Sign in
Author
|
Conference
|
Journal
|
Organization
|
Year
|
DOI
Look for results that meet for the following criteria:
since
equal to
before
between
and
Search in all fields of study
Limit my searches in the following fields of study
Agriculture Science
Arts & Humanities
Biology
Chemistry
Computer Science
Economics & Business
Engineering
Environmental Sciences
Geosciences
Material Science
Mathematics
Medicine
Physics
Social Science
Multidisciplinary
Co-authors
(39)
Karthik Venkatakrishnan
2
Rachel Neuwirth
2
Gurkamal S. Chatta
2
Michael Karol
2
Lisa L. von Moltke
2
Journals
(3)
CANCER CHEMOTHER PHARMACOL
2
CLIN THER
1
GYNECOL ONCOL
1
Keywords
(22)
Embed
Subscribe
Academic
Authors
William J. Riordan
William J. Riordan,Massachusetts Institute of Technology,Oncology,Pharmacology,Ophthalmology
Edit
William J. Riordan
Massachusetts Institute of Technology
Publications:
4
|
Citations:
19
Fields:
Oncology
,
Pharmacology
,
Ophthalmology
View FAQ about top research areas and Fields of study
Collaborated with
39 co-authors
from 2008 to 2011
|
Cited by
94 authors
Cumulative
Annual
Sort by:
Publications
(4)
BibTeX
|
RIS
|
RefWorks
Download
Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma
(
Citations: 3
)
Donna E. Reece
,
Dan Sullivan
,
Sagar Lonial
,
Ann F. Mohrbacher
,
Gurkamal Chatta
,
Chaim Shustik
,
Howard Burris
,
Karthik Venkatakrishnan
,
Rachel Neuwirth
,
William J. Riordan
,
Michael Karol
,
Lisa L. von Moltke
http://academic.research.microsoft.com/io.ashx?type=5&id=32518004&selfId1=26648569&selfId2=0&maxNumber=12&query=
Journal:
Cancer Chemotherapy and Pharmacology - CANCER CHEMOTHER PHARMACOL
, vol. 67, no. 1, pp. 57-67, 2011
A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: A Gynecologic Oncology Group study
(
Citations: 7
)
Carol Aghajanian
,
John A. Blessing
,
Kathleen M. Darcy
,
Gary Reid
,
Koen DeGeest
,
Stephen C. Rubin
,
Robert S. Mannel
,
Jacob Rotmensch
,
Russell J. Schilder
,
William Riordan
Journal:
Gynecologic Oncology - GYNECOL ONCOL
, vol. 115, no. 2, pp. 215-220, 2009
Effect of the CYP3A inhibitor ketoconazole on the pharmacokinetics and pharmacodynamics of bortezomib in patients with advanced solid tumors: A prospective, multicenter, open-label, randomized, two-way crossover drug—drug interaction study
(
Citations: 3
)
Karthik Venkatakrishnan
,
Michael Rader
,
Ramesh K. Ramanathan
,
Suresh Ramalingam
,
Eric Chen
,
William Riordan
,
William Trepicchio
,
Michael Cooper
,
Michael Karol
,
Lisa von Moltke
,
Rachel Neuwirth
,
Merrill Egorin
http://academic.research.microsoft.com/io.ashx?type=5&id=32777550&selfId1=26648569&selfId2=0&maxNumber=12&query=
Journal:
Clinical Therapeutics - CLIN THER
, vol. 31, pp. 2444-2458, 2009
A phase I and pharmacologic study of the combination of bortezomib and pegylated liposomal doxorubicin in patients with refractory solid tumors
(
Citations: 6
)
E. Claire Dees
,
Bert H. O’Neil
,
Celeste M. Lindley
,
Frances Collichio
,
Lisa A. Carey
,
Jason Collins
,
William J. Riordan
,
Anastasia Ivanova
,
Dixie Esseltine
,
Robert Z. Orlowski
Journal:
Cancer Chemotherapy and Pharmacology - CANCER CHEMOTHER PHARMACOL
, vol. 63, no. 1, pp. 99-107, 2008
Sort by:
Citations
(19 times by 18 publications)
Molecular clustering based on ERα and EIG121 predicts survival in high-grade serous carcinoma of the ovary/peritoneum
(
Citations: 1
)
Matthew P Schlumbrecht
,
Su-Su Xie
,
Gregory L Shipley
,
Diana L Urbauer
,
Russell R Broaddus
Journal:
Modern Pathology - MODERN PATHOL
, vol. 24, no. 3, pp. 453-462, 2011
Analysis of Two Commercially Available Bortezomib Products: Differences in Assay of Active Agent and Impurity Profile
Stephen R. Byrn
,
Patrick A. Tishmack
,
Mark J. Milton
,
Helgi van de Velde
Journal:
Aaps Pharmscitech
, vol. 12, no. 2, pp. 461-467, 2011
Formation and interpretation of the BMP morphogen gradient in the Drosophila embryo
Carolyn Peluso
,
David Umulis
,
Young-Jun Kim
,
Michael O'Connor
,
Mihaela Serpe
Journal:
Developmental Biology - DEVELOP BIOL
, vol. 356, no. 1, pp. 207-207, 2011
Macroautophagy modulates cellular response to proteasome inhibitors in cancer therapy
(
Citations: 3
)
William K. K. Wu
,
Kathleen M. Sakamoto
,
Manuela Milani
,
Grace Aldana-Masankgay
,
Daiming Fan
,
Kaichun Wu
,
Chung W. Lee
,
Chi H. Cho
,
Jun Yu
,
Joseph J. Y. Sung
Journal:
Drug Resistance Updates - DRUG RESIST UPDATE
, vol. 13, no. 3, pp. 87-92, 2010
Translational research in the Gynecologic Oncology Group: Evaluation of ovarian cancer markers, profiles, and novel therapies
(
Citations: 1
)
Kathleen M. Darcy
,
Michael J. Birrer
Journal:
Gynecologic Oncology - GYNECOL ONCOL
, vol. 117, no. 3, pp. 429-439, 2010
Comments